In summary, we report a novel biodegradable polymeric nanoformulation of PI3‐Kδ/HDAC6 dual inhibitor (HSB‐510) based on PLA block copolymeric system for breast cancer therapy. Here, HDAC6 is linked to breast carcinoma.